[go: up one dir, main page]

NO20000811D0 - Method of selecting a drug - Google Patents

Method of selecting a drug

Info

Publication number
NO20000811D0
NO20000811D0 NO20000811A NO20000811A NO20000811D0 NO 20000811 D0 NO20000811 D0 NO 20000811D0 NO 20000811 A NO20000811 A NO 20000811A NO 20000811 A NO20000811 A NO 20000811A NO 20000811 D0 NO20000811 D0 NO 20000811D0
Authority
NO
Norway
Prior art keywords
drug
selecting
Prior art date
Application number
NO20000811A
Other languages
Norwegian (no)
Other versions
NO20000811L (en
Inventor
Julian Cockbain
Henry R Wolfe
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO20000811D0 publication Critical patent/NO20000811D0/en
Publication of NO20000811L publication Critical patent/NO20000811L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00Methods of screening libraries
    • C40B30/04Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K1/00General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/04General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length on carriers
    • C07K1/047Simultaneous synthesis of different peptide species; Peptide libraries
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6845Methods of identifying protein-protein interactions in protein mixtures
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/195Assays involving biological materials from specific organisms or of a specific nature from bacteria
    • G01N2333/24Assays involving biological materials from specific organisms or of a specific nature from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • G01N2333/245Escherichia (G)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NO20000811A 1997-08-20 2000-02-18 Procedure for drug selection NO20000811L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9717652.3A GB9717652D0 (en) 1997-08-20 1997-08-20 Method
PCT/GB1998/002504 WO1999009416A2 (en) 1997-08-20 1998-08-20 Method of drug selection

Publications (2)

Publication Number Publication Date
NO20000811D0 true NO20000811D0 (en) 2000-02-18
NO20000811L NO20000811L (en) 2000-04-12

Family

ID=10817781

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20000811A NO20000811L (en) 1997-08-20 2000-02-18 Procedure for drug selection

Country Status (7)

Country Link
EP (1) EP1005655A2 (en)
JP (1) JP2001516029A (en)
AU (2) AU8817398A (en)
CA (1) CA2300903A1 (en)
GB (1) GB9717652D0 (en)
NO (1) NO20000811L (en)
WO (2) WO1999009417A2 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9809782D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
GB9809780D0 (en) * 1998-05-07 1998-07-08 Nycomed Imaging As Method
GB9809776D0 (en) 1998-05-07 1998-07-08 Nycomed Imaging As Method
WO2008106429A2 (en) 2007-02-26 2008-09-04 Ironwood Pharmaceuticals, Inc. Methods and compositions for the treatment of heart failure and other disorders
CA2707840A1 (en) 2007-08-20 2009-02-26 Allozyne, Inc. Amino acid substituted molecules
CN105658661B (en) * 2013-02-20 2020-07-24 卑尔根技术交易股份公司 Vaccine
EP3841111A1 (en) 2018-08-24 2021-06-30 Vestlandets Innovasjonsselskap AS Heat-stable enterotoxins mutants as antidiarrheal vaccine antigens

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5075211A (en) * 1986-03-26 1991-12-24 Genetic Systems Corporation Synthetic antigen for the detection of AIDS-related disease
US4965343A (en) * 1988-01-28 1990-10-23 Hoffmann-La Roche Inc. Method of peptide synthesis
JPH0768271B2 (en) * 1989-08-31 1995-07-26 三菱化学株式会社 Method for producing human osteocalcin
CS89491A3 (en) * 1990-04-09 1992-01-15 Chugai Pharmaceutical Co Ltd Hybrid calcitonin
US5723286A (en) * 1990-06-20 1998-03-03 Affymax Technologies N.V. Peptide library and screening systems
US5824483A (en) * 1994-05-18 1998-10-20 Pence Inc. Conformationally-restricted combinatiorial library composition and method
US5911997A (en) * 1995-06-07 1999-06-15 Connetics Corporation Relaxin-like factor and methods and uses thereof
WO1997022617A1 (en) * 1995-12-18 1997-06-26 Praecis Pharmaceuticals Incorporated Methods for identifying compounds that bind to a target

Also Published As

Publication number Publication date
WO1999009417A3 (en) 1999-08-12
WO1999009416A3 (en) 1999-10-21
GB9717652D0 (en) 1997-10-22
WO1999009417A2 (en) 1999-02-25
WO1999009416A2 (en) 1999-02-25
JP2001516029A (en) 2001-09-25
AU8816898A (en) 1999-03-08
EP1005655A2 (en) 2000-06-07
CA2300903A1 (en) 1999-02-25
NO20000811L (en) 2000-04-12
WO1999009417A9 (en) 1999-05-27
AU8817398A (en) 1999-03-08

Similar Documents

Publication Publication Date Title
MA26549A1 (en) DRUGS
NO994757L (en) Method for Oral Administration of Proteins
FI963984L (en) New oral pharmaceutical dosage form
FI973243L (en) New pharmaceutical combination
ID19343A (en) DRUG POWDER INHUB
EP0898978A4 (en) ASPIRATION TYPE DRUG APPLICATOR
FI971279L (en) Drug
EE03925B1 (en) Method for the preparation of a pharmacologically active substance
FR2767121B1 (en) DISTRIBUTOR OF DRUGS
NO995251D0 (en) Procedure for administering halotherapy
NO20042393L (en) Polymorph of a drug
BR9610214A (en) Pharmaceutical compounds
DK0868911T3 (en) Rapamycin preparations for oral administration
NO975660D0 (en) Use of benzimidazoles for the manufacture of a drug for the treatment of liver chemistry
BR9600809A (en) Medication
BR9607626A (en) New pharmaceutical naphthyl compounds
NO973610D0 (en) New pharmaceutical preparation
GB9508823D0 (en) Drug Derivatives
NO20000811D0 (en) Method of selecting a drug
EE03384B1 (en) Use of melatonin for the manufacture of a medicament
NO994083D0 (en) Selective epoxidation method for the preparation of pharmaceutical compounds
NO973611D0 (en) New pharmaceutical preparation
EE200000401A (en) Process for the preparation of a pharmaceutical preparation
DK0866699T3 (en) Use of cholinesterase inhibitors for the manufacture of a medicament for the treatment of xerostomy
NO965448L (en) Pharmaceutical compounds